{"hands_on_practices": [{"introduction": "The effectiveness of a targeted therapy, such as a monoclonal antibody, begins with its ability to find and bind to its molecular target. This exercise introduces the fundamental concept of receptor occupancy, which quantifies the fraction of target receptors bound by a drug at a given concentration. Calculating occupancy [@problem_id:4956584] is a crucial first step in predicting a drug's pharmacological effect and understanding the relationship between drug exposure and response.", "problem": "A fully human monoclonal antibody used in oncology binds a cell-surface receptor and sterically blocks its signaling. In a tumor interstitial space at steady state, the free antibody concentration is measured as $2\\,\\text{nM}$. In vitro binding experiments establish a dissociation constant $K_{D}=0.5\\,\\text{nM}$ for a single class of non-cooperative binding sites. Histology-based quantification yields a total receptor concentration in the interstitial volume of $B_{\\max}=500\\,\\text{nM}$. Assume equilibrium, one-to-one reversible binding between free receptor $R$ and antibody ligand $L$ to form the complex $RL$, with mass-action kinetics and the usual definition $K_{D}=[R][L]/[RL]$. Also assume that downstream signaling in the absence of drug is proportional to the fraction of unoccupied receptors, and that receptor bound by antibody is completely silenced (full antagonism with unit transduction).\n\nUsing only these assumptions and definitions, derive the equilibrium receptor occupancy and compute the expected fraction of signaling inhibited. Report two unitless numbers as decimals in the order: receptor occupancy, signaling inhibition. Round both to four significant figures and do not use a percent sign.", "solution": "The fundamental starting point is the reversible binding scheme under the law of mass action:\n$$\nR + L \\rightleftharpoons RL,\n$$\nwith dissociation constant defined as\n$$\nK_{D} = \\frac{[R][L]}{[RL]}.\n$$\nReceptor conservation at equilibrium gives\n$$\nB_{\\max} = [R] + [RL].\n$$\nWe seek the fraction of receptors occupied (the occupancy), defined as\n$$\nf \\equiv \\frac{[RL]}{B_{\\max}}.\n$$\nFrom the definition of $K_{D}$, solve for $[RL]$ in terms of $[L]$ and $[R]$:\n$$\n[RL] = \\frac{[R][L]}{K_{D}}.\n$$\nUse conservation to eliminate $[R]$:\n$$\n[R] = B_{\\max} - [RL].\n$$\nSubstitute into the expression for $[RL]$:\n$$\n[RL] = \\frac{(B_{\\max} - [RL])[L]}{K_{D}}.\n$$\nRearrange to solve for $[RL]$:\n$$\n[RL]\\left(1 + \\frac{[L]}{K_{D}}\\right) = \\frac{B_{\\max}[L]}{K_{D}},\n$$\nso\n$$\n[RL] = \\frac{B_{\\max}[L]}{K_{D} + [L]}.\n$$\nTherefore, the occupancy fraction is\n$$\nf = \\frac{[RL]}{B_{\\max}} = \\frac{[L]}{K_{D} + [L]}.\n$$\nNow substitute the given equilibrium free ligand concentration $[L] = 2\\,\\text{nM}$ and $K_{D} = 0.5\\,\\text{nM}$:\n$$\nf = \\frac{2}{0.5 + 2} = \\frac{2}{2.5} = 0.8.\n$$\nBecause the antibody is a full antagonist and signaling in the absence of drug is proportional to the fraction of unoccupied receptors, the fraction of signaling inhibited equals the fraction of receptors that are occupied by the antibody. Thus the predicted signaling inhibition fraction is also\n$$\n0.8.\n$$\nRounding both quantities to four significant figures yields $0.8000$ for each. The requested output order is receptor occupancy, signaling inhibition.", "answer": "$$\\boxed{\\begin{pmatrix}0.8000 & 0.8000\\end{pmatrix}}$$", "id": "4956584"}, {"introduction": "While binding affinity is key, many targeted drugs do not operate in a vacuum; they must compete with the body's own molecules. This is especially true for tyrosine kinase inhibitors (TKIs), which must outcompete high intracellular concentrations of adenosine triphosphate (ATP) to block signaling. This practice explores the principles of competitive binding [@problem_id:4956526], allowing you to calculate how the presence of a natural substrate affects the fractional inhibition achieved by a drug, a critical factor in determining its real-world potency.", "problem": "A pharmaceutical scientist is studying an adenosine triphosphate (ATP)-competitive tyrosine kinase inhibitor (TKI) in a solid tumor model. Assume the kinase has a single catalytic site that can be in one of three states: unbound, ATP-bound, or inhibitor-bound. Use the law of mass action and the rapid-equilibrium approximation for competitive binding to a single site to derive the fractional occupancy of the kinase by the inhibitor in terms of the free concentrations and equilibrium constants. Treat the Michaelis constant for ATP, denoted the Michaelis constant ($K_{M}$), as an effective dissociation constant for the ATP binding step under the rapid-equilibrium assumption.\n\nYou are given the following experimentally measured parameters under steady intracellular conditions:\n- Inhibitor dissociation constant $K_{D}^{I} = 5\\,\\text{nM}$.\n- Free intracellular inhibitor concentration $[I] = 50\\,\\text{nM}$ (achieved by dosing and confirmed by intracellular pharmacokinetic sampling).\n- ATP Michaelis constant $K_{M}^{ATP} = 100\\,\\mu\\text{M}$.\n- Intracellular ATP concentration $[ATP] = 1\\,\\text{mM}$.\n- Total kinase concentration $[E]_{T} = 50\\,\\text{nM}$ (assume this is sufficiently low that $[ATP]$ is not measurably depleted and that $[I]$ refers to the free, unbound inhibitor concentration).\n\nDefine the fractional inhibition as the fraction of kinase molecules bound by inhibitor at equilibrium. Starting from the mass-action binding equilibria and without invoking any pre-memorized shortcut formulas, derive the expression for this fraction under competitive binding of ATP and inhibitor to the same site, and compute its numerical value for the given conditions.\n\nExpress your final result as a decimal fraction with no units, and round your answer to four significant figures.", "solution": "The problem requires the derivation of the fractional occupancy of a kinase by a competitive inhibitor, given the concentrations of the inhibitor and the natural substrate (ATP), as well as their respective binding/dissociation constants. The system is described by a set of reversible binding equilibria under the rapid-equilibrium approximation.\n\nLet $E$ represent the free kinase enzyme, $I$ the inhibitor, and $A$ the substrate ATP. According to the problem statement, the kinase has a single site where both the inhibitor and ATP bind competitively. The possible states for the enzyme are free ($E$), inhibitor-bound ($EI$), and ATP-bound ($EA$).\n\nThe binding reactions are governed by the law of mass action:\n1.  The inhibitor $I$ binds to the free enzyme $E$ to form the complex $EI$:\n    $$E + I \\rightleftharpoons EI$$\n    The equilibrium is described by the inhibitor dissociation constant, $K_{D}^{I}$:\n    $$K_{D}^{I} = \\frac{[E][I]}{[EI]}$$\n    where $[E]$, $[I]$, and $[EI]$ are the molar concentrations of the free enzyme, free inhibitor, and enzyme-inhibitor complex, respectively, at equilibrium.\n\n2.  The substrate ATP ($A$) binds to the free enzyme $E$ to form the complex $EA$:\n    $$E + A \\rightleftharpoons EA$$\n    The problem states that the Michaelis constant for ATP, $K_{M}^{ATP}$, should be treated as an effective dissociation constant for this binding step. Therefore:\n    $$K_{M}^{ATP} = \\frac{[E][A]}{[EA]}$$\n    where $[A]$ and $[EA]$ are the molar concentrations of free ATP and the enzyme-ATP complex, respectively.\n\nThe total concentration of the kinase, $[E]_{T}$, is the sum of the concentrations of all its forms:\n$$[E]_{T} = [E] + [EI] + [EA]$$\n\nThe fractional inhibition, which we denote as $\\theta_{I}$, is defined as the fraction of total kinase molecules bound by the inhibitor. Mathematically, this is expressed as:\n$$\\theta_{I} = \\frac{[EI]}{[E]_{T}}$$\n\nTo derive an expression for $\\theta_{I}$ in terms of the given constants and concentrations, we first express the concentrations of the complexed forms, $[EI]$ and $[EA]$, in terms of the free enzyme concentration, $[E]$, using their respective equilibrium constant definitions:\nFrom the definition of $K_{D}^{I}$:\n$$[EI] = \\frac{[E][I]}{K_{D}^{I}}$$\nFrom the definition of $K_{M}^{ATP}$:\n$$[EA] = \\frac{[E][A]}{K_{M}^{ATP}}$$\n\nNow, we substitute these expressions into the equation for the total enzyme concentration:\n$$[E]_{T} = [E] + \\frac{[E][I]}{K_{D}^{I}} + \\frac{[E][A]}{K_{M}^{ATP}}$$\nWe can factor out the free enzyme concentration $[E]$:\n$$[E]_{T} = [E] \\left( 1 + \\frac{[I]}{K_{D}^{I}} + \\frac{[A]}{K_{M}^{ATP}} \\right)$$\n\nNext, we substitute the expressions for $[EI]$ and $[E]_{T}$ into the formula for fractional inhibition $\\theta_{I}$:\n$$\\theta_{I} = \\frac{\\frac{[E][I]}{K_{D}^{I}}}{[E] \\left( 1 + \\frac{[I]}{K_{D}^{I}} + \\frac{[A]}{K_{M}^{ATP}} \\right)}$$\nThe concentration of free enzyme, $[E]$, cancels from the numerator and the denominator, yielding the final expression for fractional inhibition:\n$$\\theta_{I} = \\frac{\\frac{[I]}{K_{D}^{I}}}{1 + \\frac{[I]}{K_{D}^{I}} + \\frac{[A]}{K_{M}^{ATP}}}$$\nThis expression gives the fractional occupancy of the enzyme by the inhibitor as a function of the free inhibitor and substrate concentrations, normalized by their respective dissociation constants.\n\nNow, we compute the numerical value of $\\theta_{I}$ using the provided parameters:\n- Inhibitor dissociation constant: $K_{D}^{I} = 5\\,\\text{nM}$\n- Free inhibitor concentration: $[I] = 50\\,\\text{nM}$\n- ATP Michaelis constant: $K_{M}^{ATP} = 100\\,\\mu\\text{M}$\n- ATP concentration: $[A] = [ATP] = 1\\,\\text{mM}$\n\nTo ensure consistency, we first calculate the dimensionless ratios.\nThe ratio for the inhibitor is:\n$$\\frac{[I]}{K_{D}^{I}} = \\frac{50\\,\\text{nM}}{5\\,\\text{nM}} = 10$$\nThe ratio for the ATP requires unit conversion. Let's convert $[ATP]$ to $\\mu\\text{M}$:\n$$[ATP] = 1\\,\\text{mM} = 1000\\,\\mu\\text{M}$$\nNow, the ratio for ATP is:\n$$\\frac{[A]}{K_{M}^{ATP}} = \\frac{1000\\,\\mu\\text{M}}{100\\,\\mu\\text{M}} = 10$$\nSubstituting these two ratios into the derived expression for $\\theta_{I}$:\n$$\\theta_{I} = \\frac{10}{1 + 10 + 10} = \\frac{10}{21}$$\n\nFinally, we compute the decimal value and round to four significant figures as requested:\n$$\\theta_{I} = \\frac{10}{21} \\approx 0.476190476...$$\nRounding to four significant figures gives:\n$$\\theta_{I} \\approx 0.4762$$\nThis result signifies that at the given intracellular concentrations of the inhibitor and ATP, approximately $47.62\\%$ of the target kinase molecules are bound by the inhibitor.", "answer": "$$\\boxed{0.4762}$$", "id": "4956526"}, {"introduction": "To achieve the target engagement calculated in the previous exercises, a sufficient concentration of the drug must be maintained in the body over time. This is the realm of pharmacokinetics, which governs how a drug's concentration changes based on dosing and the body's handling of it. This problem [@problem_id:4956615] guides you through calculating the steady-state trough concentration, a key pharmacokinetic parameter that helps ensure a therapy remains effective throughout the entire dosing interval.", "problem": "A patient with estrogen receptorâ€“positive breast cancer is prescribed a once-daily oral aromatase inhibitor (AI) therapy. Assume a one-compartment model with linear, first-order elimination and rapid absorption (absorption rate constant much larger than the elimination rate constant so that input can be treated as an instantaneous oral bolus with bioavailability). The following parameters are known: oral bioavailability $F = 0.8$, systemic clearance $CL = 15\\,\\text{L/h}$, dose per administration $D = 1\\,\\text{mg}$, dosing interval $\\tau = 24\\,\\text{h}$, and elimination half-life $t_{1/2} = 48\\,\\text{h}$. Using fundamental pharmacokinetic definitions and laws (including the relationship between half-life and the elimination rate constant, the definition of clearance, and superposition for repeated dosing), derive and calculate the steady-state trough concentration immediately before the next dose. Express your final concentration in $\\text{mg/L}$ and round your answer to three significant figures.", "solution": "The objective is to find the steady-state trough concentration, $C_{ss,min}$, which is the minimum concentration just before the administration of the next dose after a steady state has been reached.\n\nThe concentration $C(t)$ of a drug at time $t$ after a single oral dose (modeled as an instantaneous bolus) in a one-compartment model is given by:\n$$C(t) = C_0 \\exp(-k_e t) = \\frac{F \\cdot D}{V_d} \\exp(-k_e t)$$\nwhere $F$ is the bioavailability, $D$ is the dose, $V_d$ is the volume of distribution, and $k_e$ is the first-order elimination rate constant.\n\nFor a multiple dosing regimen with a constant dose $D$ administered at a regular interval $\\tau$, the principle of superposition applies. At steady state, the concentration profile is periodic. The trough concentration, $C_{ss,min}$, is the concentration at time $\\tau$ after a dose, resulting from the sum of the residual concentrations of all previous doses.\n$$C_{ss,min} = \\sum_{n=1}^{\\infty} \\frac{F \\cdot D}{V_d} \\exp(-k_e (n\\tau)) = \\frac{F \\cdot D}{V_d} \\sum_{n=1}^{\\infty} (\\exp(-k_e \\tau))^{n}$$\nThis is a geometric series with first term $a = \\exp(-k_e \\tau)$ and common ratio $r = \\exp(-k_e \\tau)$. The sum is $\\frac{a}{1-r}$.\n$$C_{ss,min} = \\frac{F \\cdot D}{V_d} \\left( \\frac{\\exp(-k_e \\tau)}{1 - \\exp(-k_e \\tau)} \\right)$$\nThis can be rewritten using the accumulation factor, $R = \\frac{1}{1 - \\exp(-k_e \\tau)}$. The concentration after a single dose at time $\\tau$ is $C_1(\\tau) = \\frac{F \\cdot D}{V_d} \\exp(-k_e \\tau)$. The trough concentration at steady state is the accumulation of this residual concentration:\n$$C_{ss,min} = C_1(\\tau) \\cdot \\frac{1}{1 - \\exp(-k_e \\tau)} = \\frac{F \\cdot D}{V_d} \\frac{\\exp(-k_e \\tau)}{1 - \\exp(-k_e \\tau)}$$\nThe problem provides systemic clearance, $CL$, instead of the volume of distribution, $V_d$. The fundamental relationship between these parameters is:\n$$CL = k_e \\cdot V_d$$\nWe can rearrange this to express $V_d$ in terms of $CL$ and $k_e$:\n$$V_d = \\frac{CL}{k_e}$$\nSubstituting this expression for $V_d$ into the equation for $C_{ss,min}$:\n$$C_{ss,min} = \\frac{F \\cdot D}{(CL/k_e)} \\frac{\\exp(-k_e \\tau)}{1 - \\exp(-k_e \\tau)} = \\frac{F \\cdot D \\cdot k_e}{CL} \\frac{\\exp(-k_e \\tau)}{1 - \\exp(-k_e \\tau)}$$\nThis is the final formula in terms of the given parameters. The next step is to calculate the numerical values.\n\nFirst, we calculate the elimination rate constant, $k_e$, from the given elimination half-life, $t_{1/2} = 48\\,\\text{h}$.\n$$k_e = \\frac{\\ln(2)}{t_{1/2}} = \\frac{\\ln(2)}{48\\,\\text{h}}$$\nNext, we calculate the dimensionless product $k_e \\tau$, using $\\tau = 24\\,\\text{h}$.\n$$k_e \\tau = \\left(\\frac{\\ln(2)}{48\\,\\text{h}}\\right) \\cdot (24\\,\\text{h}) = \\frac{\\ln(2)}{2}$$\nNow, we can evaluate the exponential terms in the formula for $C_{ss,min}$:\n$$\\exp(-k_e \\tau) = \\exp\\left(-\\frac{\\ln(2)}{2}\\right) = \\exp(\\ln(2^{-1/2})) = 2^{-1/2} = \\frac{1}{\\sqrt{2}}$$\nSubstituting this into the fractional part of the equation:\n$$\\frac{\\exp(-k_e \\tau)}{1 - \\exp(-k_e \\tau)} = \\frac{1/\\sqrt{2}}{1 - 1/\\sqrt{2}} = \\frac{1/\\sqrt{2}}{(\\sqrt{2}-1)/\\sqrt{2}} = \\frac{1}{\\sqrt{2}-1}$$\nNow we substitute all the values into the equation for $C_{ss,min}$:\n- $F = 0.8$\n- $D = 1\\,\\text{mg}$\n- $CL = 15\\,\\text{L/h}$\n- $k_e = \\frac{\\ln(2)}{48}\\,\\text{h}^{-1}$\n\n$$C_{ss,min} = \\frac{F \\cdot D}{CL} \\cdot k_e \\cdot \\left(\\frac{1}{\\sqrt{2}-1}\\right)$$\n$$C_{ss,min} = \\left(\\frac{0.8 \\cdot 1\\,\\text{mg}}{15\\,\\text{L/h}}\\right) \\cdot \\left(\\frac{\\ln(2)}{48\\,\\text{h}}\\right) \\cdot \\left(\\frac{1}{\\sqrt{2}-1}\\right)$$\nThe units are $(\\text{mg}/\\text{(L/h)}) \\cdot (\\text{h}^{-1}) = \\text{mg} \\cdot \\text{h}/\\text{L} \\cdot \\text{h}^{-1} = \\text{mg/L}$, which is correct.\nLet's compute the numerical value:\n$$C_{ss,min} = \\frac{0.8}{15} \\cdot \\frac{\\ln(2)}{48} \\cdot \\frac{1}{\\sqrt{2}-1} \\,\\text{mg/L}$$\n$$C_{ss,min} \\approx \\frac{0.8}{15} \\cdot \\frac{0.693147}{48} \\cdot \\frac{1}{1.414214-1} \\,\\text{mg/L}$$\n$$C_{ss,min} \\approx (0.053333) \\cdot (0.0144406) \\cdot \\left(\\frac{1}{0.414214}\\right) \\,\\text{mg/L}$$\n$$C_{ss,min} \\approx (0.00077016) \\cdot (2.41421) \\,\\text{mg/L}$$\n$$C_{ss,min} \\approx 0.0018590 \\,\\text{mg/L}$$\nRounding the result to three significant figures as requested:\n$$C_{ss,min} \\approx 0.00186 \\,\\text{mg/L}$$", "answer": "$$\\boxed{0.00186}$$", "id": "4956615"}]}